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Abstract 
Cardiopulmonary exercise testing (CPEX) is a valuable clinical tool that has proven indications 
within the fields of cardiovascular, respiratory and pre-operative medical care. Validated uses 
include investigation of the underlying mechanism in patients with breathlessness, monitoring 
functional status in patients with known cardiovascular disease and pre-operative functional 
state assessment. An understanding of the underlying physiology of exercise, and the 
perturbations associated with pathological states, is essential for healthcare professionals to 
provide optimal patient care. Healthcare professionals may find performing CPEX to be 
daunting, yet this is often due to a lack of local expertise and guidance with testing. We outline 
the indications for CPEX within the clinical setting, present a typical protocol that is easy to 
implement, explain the key underlying physiological changes assessed by CPEX, and review 
the evidence behind its use in routine clinical practice. There is mounting evidence for the use 
of CPEX clinically, and an ever-growing utilisation of the test within research fields; a sound 
knowledge of CPEX is essential for healthcare professionals involved in routine patient care.  
Keywords: cardio-pulmonary exercise testing; CPEX; exercise testing; CPEX evidence; guide 
to CPEX; guide to exercise testing; understanding CPEX; CPEX supervision; CPEX training; 
basic CPEX; CPEX indications. 
Key messages: 
1. CPEX provides valuable insight into pathophysiology of a breathless patient. 
2. CPEX is a safe test and increasingly performed on high risk patients. 
3. There is strong evidence for CPEX data in monitoring heart failure patients and 
predicting peri-operative risk in lung and abdominal surgery. 
4. Knowledge of CPEX is essential for the healthcare professional, with mounting 
evidence in the field. 
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Introduction 
Cardio-pulmonary exercise (CPEX) testing is used to establish the degree of exercise 
limitation, to identify the underlying mechanisms responsible in patients with breathlessness, 
and to monitor functional status in cardiovascular disease (1). It is an important prognostic tool 
and decision-aid in the assessment of perioperative risk (2). In addition to the routine 
parameters measured during the exercise electrocardiogram (ECG) stress test, CPEX can 
provide measurements of oxygen (O2) consumption, carbon dioxide (CO2) production, and 
lung ventilation to provide valuable information about respiratory, cardiovascular and muscle 
metabolic function as well as the subject’s effort during the test. Despite its useful diagnostic 
and prognostic functions, and established role in several guidelines for management of 
cardiovascular diseases, CPEX has remained largely a research or sport sciences tool, and is 
grossly under-utilized in clinical practice.  This is commonly due to a lack of local expertise or 
awareness about the utility of CPEX among physicians. We review the indications and 
contraindications for CPEX and describe a standard protocol for cardiopulmonary stress 
testing. Additionally, we propose a practical reporting and data interpretation guide for the 
junior cardiology/respiratory trainee.   
Indications and contraindications of CPEX 
The diagnostic and prognostic indications, along with the contraindications for CPEX testing 
are listed in Table 1. The ATS/ACCP guidelines (2003) include these absolute 
contraindications to CPEX (3), however recently the test has been performed safely in 
conditions like severe aortic stenosis (4).  Indications to perform the test are also increasing, as 
in the diagnosis of heart failure with normal ejection fraction (5) and in exercise prescription 
for heart failure patients (6).  
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Table 1: Indications and contraindications of cardio-pulmonary exercise testing 
Indications  
Diagnostic  
Breathlessness of unknown cause 
Cardiac ischemia detection  
Prognostic  
Heart failure (prioritization for heart transplantation)  
Perioperative risk in patients undergoing major surgery  
Chronic obstructive pulmonary disease (COPD)   
Pulmonary hypertension 
Risk of lung resection 
Congenital heart disease 
Absolute Contraindications 
Acute myocardial infarction (3-5 days) 
Acute myocarditis 
Severe symptomatic aortic stenosis 
Uncontrolled heart failure 
Uncontrolled arrhythmia 
Dissecting aneurysm 
Resting Oxygen saturation of <86% 
 
Preparation for CPEX Assessment 
Patients are advised to avoid caffeine, nicotine and food for two hours prior to CPEX (7). 
Enquiry into the patient’s past medical history, medications, any limitations and any special 
requirements for participation in CPEX should be made. If the patient has a pacemaker, 
defibrillator or a cardiac resynchronisation device, guidance of the cardiac physiologist or 
rhythm management specialist should be sought. Additional assessments which should be 
completed in advance of CPEX include: clinical examination of the cardiovascular, respiratory 
and peripheral vascular systems, ECG, resting oxygen saturation,  blood pressure (BP), 
spirometry,  including vital capacity and forced expiratory volume in the first second 
(FEV1).Commonly used abbreviations in CPEX are given in table 2. 
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Table 2: Commonly used abbreviations in CPEX (8) 
VO2 (oxygen uptake) 
Amount of oxygen extracted from inspired 
gas per unit time  
(may be expressed as an absolute value 
(ml/min) or corrected for weight (ml/kg/min)) 
VCO2 
Amount of carbon dioxide exhaled from the 
body per unit time (usually, per minute) 
VO2 max 
Maximum oxygen uptake achievable 
(confirmed by repeated tests), despite further 
work rate increases 
Peak VO2 
Highest VO2 achieved during presumed 
maximal effort (as indicated by RER>1.15), 
for that test 
R (or Respiratory Exchange Ratio) 
Ratio of carbon dioxide output to oxygen 
uptake (VCO2/VO2) 
VE  
Volume of air inhaled or exhaled by the body 
in 1 minute 
MVV (Maximum Voluntary Ventilation) 
The maximum potential ventilation achievable 
(estimated as FEV1X40) 
Anaerobic threshold (AT) 
Exercise limit above which the subject’s 
anaerobic high energy phosphate production  
supplements aerobic metabolism 
Breathing Reserve 
The difference between maximum voluntary 
ventilation and the achieved maximum 
exercise minute ventilation 
 
Checklist before the test 
 Clinical history 
 Drug history 
 Device history (pacemakers/defibrillators) 
 Clinical examination 
 Electrocardiogram 
 Blood pressure 
 Oxygen saturation 
 Recent haemoglobin 
 6 
 
Protocol 
The patient is prepared by connecting them to an ECG monitor and facemask. The facemask 
is tested for any air-leak and connected to the gas analyser. An alternative to facemask is 
mouthpiece with a nose-clip. Saliva dribbling from the mouthpiece is however a problem 
especially at peak exercise. A pulse oximeter and sphygmomanometer are attached. Oxygen 
saturation could be measured either through a finger or earlobe probe (3). New forehead sensors 
are another alternative.  
Incremental exercise testing can either be performed on a treadmill or an electronically-braked 
cycle.  Treadmills are widely used in USA and UK (9), and are a popular method allowing 
most patients to exercise to their maximal physical limit, achieving satisfactory end-points. 
Cycle ergometers are advantageous for quantifying work-rate accurately and additionally 
enable clinicians to gain arterial blood gas (ABG) samples if necessary. People with 
musculoskeletal limitations or imbalance that might limit weight-bearing may prefer the cycle 
ergometer, however hamstring fatigue could stop cycle exercise before true peak VO2 is 
reached (9). The peak VO2 achieved on cycle is usually 10-20% lower than that on a treadmill 
(9). Figure 1 shows a patient performing CPEX on a cycle ergometer. 
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Figure 1: CPEX test performed on a cycle ergometer 
1. ECG monitor 
2. Gas exchange monitor 
3. Saturations probe 
4. Oxygen and carbon dioxide sampler 
 
 
Current software calculates the maximum watts achievable automatically, based on the 
patient’s sex, age, height, and weight. Then a protocol is selected to reach the maximum 
exercise in 10-minutes, usually by dividing likely maximum watts by 10. The patient should 
be encouraged to exercise to his/her maximum physical limit, so that O2 consumption at peak 
exercise can be measured.  
Several protocols with different increments in workload exist; a typical example is presented 
in Table 3. Following a 2-minute warm-up period, the exercise starts with speed and gradient 
increased by 1 km/hour and 1% respectively every minute. Less fit patients can use a protocol 
with half a kilometre speed increase every minute. The operator records the reason for stopping 
the test at the end. 
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Table 3: Example of a typical treadmill CPEX protocol  
 Warm-
up 
2 mins 
Stage 1 
1 min 
Stage 2 
1 min 
Stage 3 
1 min 
Stage 4 
1 min 
Stage 5 
1 min 
Stage 6 
1 min 
Stage 7 
1 min 
Stage 8 
1 min 
Stage 9 
1 min 
Speed 
Kilometre/hour 
2 1 2 3 4 5 6 7 8 3 
Gradient 0% 1% 2% 3% 4% 5% 6% 7% 8% 0% 
 
Patients should be monitored closely for complications. Table 4 lists the indications for 
terminating the test early. 
Table 4 : Indications for terminating a CPEX test (3)  
Symptoms and signs 
 
Limiting chest pain 
Dizziness 
Poor co-ordination 
Sudden pallor 
Confusion 
Measurements 
 
Significant ECG changes suggesting ischemia (ST depression >3 mm, ST elevation, LBBB) 
Second or third degree heart block 
Ventricular tachycardia 
Supraventricular tachycardia, new onset atrial fibrillation 
Fall in systolic blood pressure of >20 mmHg 
Severe desaturation to <80% 
 
Physiological parameters  
Anaerobic threshold 
Oxygen (O2) consumption and carbon dioxide (CO2) production increase with incremental 
workload on exercise. CO2 production is linearly related to the amount of O2 consumed during 
exercise, until the onset of anaerobic metabolism (3). The lactate produced by anaerobic 
metabolism contributes to additional CO2 production, measured in the expired air from this 
time point, resulting in a disproportionate increase in CO2. This inflection point between the 
linear component and the progressively greater increase in CO2 production relative to the O2 
consumption is called the anaerobic threshold (10).  An example is shown in figure 3. 
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Peak and Max VO2 
O2 consumption obtained at peak exercise (averaged over 60 seconds) is called peak VO2 
(PVO2). A peak VO2 <85% of that predicted for age and gender, indicates significant exercise 
limitation (3). Normal age and sex specific values for Peak VO2 have been defined in various 
studies (11, 12). At maximal exercise, the VO2 consumption plateaus despite incremental 
increases in workload. This state is achievable in healthy adults (13). Max VO2 is a term used 
to denote the maximum O2 consumption possible for that subject, and is measured by several 
constant-work-rate exercise tests, each at varying workloads. Peak VO2 achieved in 
incremental testing is usually very close to the Max VO2.  Max VO2 is not routinely used in 
the clinical setting.  
Maximum Voluntary Ventilation (MVV) 
Maximum Voluntary Ventilation (MVV) is estimated from pre-test FEV1 obtained by 
spirometry and multiplied by maximum respiratory rate (MVV = FEV1X40). Breathing reserve 
is then calculated by subtracting the ventilatory equivalent, (VE, expressed in litres/minute) 
measured at peak exercise from the MVV (BR= MVV-peak VE [normal >11 litres]). Breathing 
reserve is preserved in patients with cardiac limitation and in those with deconditioning, but is 
usually reduced to <11L in patients with respiratory disease (14).  
Lung Dead Space 
The ratio of the lung dead space (VD) to the tidal volume (VT) is another important 
measurement. The VD/VT is increased in patients with obstructive or restrictive lung diseases 
and in pulmonary vascular disease (15-17). VD/VT can be calculated by the formula: 
VD/VT= (PaCO2-PECO2)/PaCO2  
[PaCO2-partial pressure of arterial CO2 (blood gas measurement); PECO2-patial pressure of CO2 in 
expired air (CPEX measurement) (18)] 
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Ventilation-Perfusion mismatch 
Arterial Blood Gas measurements can provide valuable additional information. The difference 
between alveolar and arterial O2 levels [P(A-a)O2] is usually between 20-30 mm Hg and this 
does not increase during exercise in normal subjects. In patients with lung disease or pulmonary 
vascular disease the difference is exaggerated during exercise due to ventilation-perfusion 
(V/Q) mismatch. Additionally, the difference between arterial and end-tidal CO2 levels [P(a-
ET)CO2] remains positive throughout exercise in patients with lung disease, again due to V/Q 
mismatch (18).  
When ventilation (VE on Y axis) is plotted against carbon dioxide (VCO2 on the X axis), the 
relationship is linear until the anaerobic threshold is reached, with a slope of 23-28 degrees. 
The relationship is steeper in conditions associated with increased VD/VT ratio such as heart 
failure, pulmonary vascular disease, interstitial lung disease and COPD, while it is normal in 
patients with exercise limitation due to deconditioning (3,19). The slope is measured from the 
beginning of exercise to just after the anaerobic threshold, as shown in figure 2. The VE/VCO2 
slope increases with age in normal subjects. A value of <30 degrees is considered normal.  
Figure 2: VE/VCO2 slope measurement-The slope is measured from the beginning to just after the 
anaerobic threshold. (AT-anaerobic Threshold, VE-ventilation per minute, VCO2- CO2 produced per 
minute) 
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Analysis and interpretation 
A peak VO2 of <85% predicted (for age and gender) indicates significant exercise limitation 
(3).  
Respiratory Exchange ratio  
Respiratory Exchange Ratio (RER or simply R) is the ratio of the CO2 production to O2 
consumption (RER=VCO2/VO2). Once anaerobic metabolism begins, RER progressively 
increases. A RER of >1.15 at peak exercise indicates an adequate exercise test (3). Current 
software measures RER automatically and is displayed throughout the test. 
Anaerobic threshold measurement 
Anaerobic threshold can be identified from several scatter graphs obtained by automatic 
software by plotting gas exchange markers against each other. The V-slope method, where the 
VCO2 is plotted against VO2 is the preferred method (see Figure 3). Other graphs used for 
determining the anaerobic threshold are VO2, VCO2 against time (see Figure 4), VE/VCO2, 
VE/VO2 against time, and PETCO2, PETO2 against time.  
 
Figure 3: V-slope method for detecting anaerobic threshold – NB: this is independent of the subject’s ventilatory 
response. (AT-Anaerobic Threshold) 
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Figure 4: Another method for detecting anaerobic threshold. VO2 and VCO2 plotted against time 
  
Heart disease 
Oxygen consumption per heart rate (HR) (termed “oxygen pulse”) can be calculated by 
dividing the Oxygen consumption by HR, and this rises steadily throughout exercise. A fall of 
oxygen pulse with increasing workload indicates a fall in cardiac output (Figure 5). A normal 
breathing reserve, low VO2 at anaerobic threshold (VO2 at anaerobic threshold (AT) of <40% 
of predicted Peak VO2)), flattening oxygen pulse, and high VE/VCO2 slope indicate to a 
cardiac pathology (3). Flattening of the O2 pulse in a person with normal left ventricular 
function and spirometry could suggest myocardial ischemia, and this precedes ECG changes 
(20).  
Figure 5: Oxygen pulse in different subjects 
A- Healthy volunteer.  VO2 pulse increases steadily with work rate 
B- Myocardial ischemia. Late flattening at high workload caused by myocardial dyskinesia 
C- Dilated cardiomyopathy. Early flattening of VO2 pulse 
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Patients with a patent foramen ovale (PFO) may develop a right-to-left cardiac shunt during 
exercise, when the right atrial pressure exceeds that of the left atrium due to functional 
pulmonary hypertension (21). This may cause an abrupt decrease in the partial pressure of the 
exhaled CO2 (PETCO2), with simultaneous abrupt increases in VE/VCO2, VE/VO2 (due to 
increase in minute ventilation, VE) and a drop in arterial O2 saturation (21). 
Lung disease 
An abnormal spirometry, high VD/VT, desaturation during exercise, low breathing reserve, 
and increase in alveolar-arterial O2 gradient [(A-a)O2] indicate respiratory pathology (3). 
Normal individuals exhaust their cardiovascular potential at peak exercise. Their breathing 
reserve is preserved (>11L) at peak exercise, indicating that the limitation to further exercise 
is the cardiovascular system (3). One exception to this are athletes who have excellent 
cardiovascular fitness; they can deplete their breathing reserve at peak exercise to <11 L, but 
achieve a supra-normal peak VO2 (22). 
Deconditioning 
A low peak VO2, normal VE/VCO2 slope, normal VO2 at anaerobic threshold, and preserved 
breathing reserve indicate deconditioning (3). A simplified diagnostic approach is shown in 
Figure 6. 
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Figure 6: Simplified diagnostic flowchart 
 
Evidence base  
Heart Failure 
CPEX is a cornerstone test in identifying heart failure patients for heart transplantation; a peak 
VO2<14 mL/kg/min in patients not on beta-blockers and peak VO2<12 mL/kg/min in patients 
on beta-blockers is the current recommendation for consideration for heart transplantation (23-
25).  
VE/VCO2 slope is another predictor of mortality in heart failure patients. Gitt et al showed a 
low VO2 at anaerobic threshold (AT) of <11 mL/kg/min and a high VE/VCO2 slope of >34 
degrees at AT were strong predictors of 6 month prognosis in heart failure patients (26). 
However, the VE/VCO2 slope is yet to find a place in cardiac transplant guidelines. 
Lung resection 
In the case of lung tumour resection surgery, Beckles’ et al review of the literature (27) showed 
lung cancer patients with: 
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1. Peak VO2 of >20 were not at increased risk of complications  
2. Peak VO2 of <15 were at increased risk of post-operative complications 
3. Peak VO2 of <10 were at very high risk of peri-operative complications 
CPEX is not necessary in all patients undergoing lung resection, but to risk-stratify patients 
with an FEV1 or diffusion capacity <80% of predicted on pre-operative testing (28). 
Abdominal surgery 
 CPEX is increasingly used for risk stratification in patients with known cardiovascular and 
respiratory disease being considered for major non-cardiac surgery. Current evidence is: 
1. VO2 at AT of >11 mL/kg/min combined with a VE/VCO2 slope of <35 are predictors for 
low cardio-vascular risk after major abdominal surgery (29, 30). 
2. A VO2 at AT of >11 mL/kg/min is correlated with improved post-operative survival in open 
and endo-vascular aortic surgery (31). Nagamatsu et al showed that in patients undergoing 
oesophagectomy, a low peak VO2 was associated with increased cardiovascular complications 
(32). They concluded that a peak VO2 of <800 ml/m2 is associated with a higher risk. 
Reporting 
A standard reporting format includes pre-test observations, test findings and interpretation. An 
example is given below. In our department, an experienced cardiologist reports all CPEX’s. 
An accurate interpretation of the test should be made available within 72 hours; this ought to 
be earlier if the findings are significantly abnormal (33). A sample reporting tool is shown in 
table 5. 
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Table 5: Sample reporting tool for cardio-pulmonary exercise test 
Name                                                                                    
Age                                                    
DOB 
Hospital ID 
Height 
Weight 
BMI 
Ideal body weight 
Haemoglobin  
Smoking status 
Spirometry: 
FEV1 
FVC 
FEV1/FVC 
KCO 
MVV 
Exercise test details: 
Protocol 
Duration of exercise 
Reason for stopping the test 
 
Resting heart rate                                                                 Peak Heart Rate 
Resting blood pressure                                                        Peak blood pressure 
Resting Oxygen saturation                                                  Peak Oxygen Saturation 
 
Exercise test findings: 
Peak Respiratory Exchange Ratio (RER) 
Predicted Peak VO2  
Peak VO2                                          
Peak VO2/ Predicted peak VO2 % 
VO2 at Anaerobic Threshold 
Peak Ventilation (VE) 
Breathing reserve 
 
VE/VCO2  slope 
Oxygen Pulse (VO2/heart rate) at peak exercise 
ΔVO2/Work rate 
VD/VT (if blood gas measured) 
PETCO2 at Rest                Peak Exercise 
Peak PETCO2                      
ECG changes 
Interpretation 
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Supervision and monitoring 
The risk of acute myocardial infarction (AMI) during an exercise test is 1 in 2500 and risk of 
death is 1 in 10000 cases (34). The physician in-charge of the exercise laboratory decides on 
the appropriateness of the request for testing, and the degree of supervision needed depending 
on the specific clinical situation. In patients who have had a recent AMI (7-10 days), severe 
valvular stenosis, or complex arrhythmias, direct physician supervision is indicated (35). In 
most other cases appropriately trained physiologists and specialist nurses can conduct the test 
safely, with the physician in the immediate vicinity. Two people are required to conduct the 
test, both qualified in cardio-pulmonary resuscitation (36). Blood pressure should be measured 
every 2-3 minutes and more frequently in high risk patients (13). Continuous ECG monitoring 
is mandatory during the test and should be continued 6 minutes into recovery (13).Manual 
measurement of blood pressure is still the preferred method during stress test (34). Staff 
performing the test should be aware of the indications for exercise test and be able to recognise 
adverse events (13).  
The AHA guidelines (2000) recommend that a physician in-charge should have participated in 
50 procedures over a dedicated 4 week period to achieve competence in supervision and 
reporting of exercise tests, and should continue to perform 25 cases per year to preserve 
competence (35). The physician is responsible for data interpretation and suggesting further 
evaluation and testing (33). The physician should also maintain advanced cardiovascular life 
support competence. The AHA guidelines detail the cognitive skills required for performing 
and interpreting the test (35). 
The exercise laboratory should be a spacious room and have the necessary equipment for 
advanced cardiac life support. Each laboratory should have a written emergency plan and all 
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personnel should rehearse it on a regular basis (36). Written informed consent is required prior 
to the exercise test (9). 
Conclusion 
CPEX testing is a relatively safe non-invasive tool which provides excellent diagnostic and 
prognostic information in patients with heart or lung disease. It should be utilized as a 
complementary diagnostic tool in the investigation of breathless patients, along with chest X-
ray, echocardiography, pulmonary angiography, right heart catheterisation, and coronary 
angiography. 
It is increasingly used in pre-operative risk assessment, cardiac and pulmonary rehabilitation, 
and adult congenital heart disease. With increasing applications and understanding, a sound 
grasp of the nuances of CPEX testing is mandatory for the cardiac, pulmonary and general 
physician. 
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